Canada markets close in 3 hours 34 minutes

InnoCan Pharma Corporation (INNO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2300-0.0050 (-2.13%)
As of 10:49AM EDT. Market open.
Full screen
Previous Close0.2350
Open0.2450
Bid0.2250 x N/A
Ask0.2300 x N/A
Day's Range0.2300 - 0.2450
52 Week Range0.1850 - 0.4100
Volume12,508
Avg. Volume78,227
Market Cap65.708M
Beta (5Y Monthly)3.01
PE Ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Innocan Pharma Advances Liposomal CBD with Positive Response from FDA Following Successful Pre-IND Meeting

    Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it has received a positive response from the U.S. Food and Drug Administration (FDA) following Innocan's successful pre-Investigational New Drug (pre-IND) Type B meeting with the FDA held in July, for its lead drug product Liposomal Technology-CBD (LPT-CBD).

  • CNW Group

    Innocan Pharma Announces Closing of Private Placement and Grant of Stock Options

    Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that it has completed its previously announced non-brokered private placement offering of 5,025,725 units of the Company (the "Units") at a price of C$0.22 per Unit for gross proceeds of C$1,105,659.50 (the "Offering").

  • CNW Group

    Innocan Pharma's Subsidiary BI Sky Global Successfully Completes FDA MoCRA Registration

    Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that its subsidiary, BI Sky Global (BI), successfully completed the registration of all its products under the FDA's Modernization of Cosmetics Regulation Act of 2022 (MoCRA).